Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.66) by 46.97 percent. This is a 67.45 percent increase over losses of $(2.98) per share from the same period last year. The company reported quarterly sales of $901.000 thousand which missed the analyst consensus estimate of $1.400 million by 35.64 percent. This is a 25.90 percent decrease over sales of $1.216 million the same period last year.